Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Whitehawk Therapeutics (WHWK) Cost of Revenue (2022 - 2025)

Whitehawk Therapeutics (WHWK) has disclosed Cost of Revenue for 4 consecutive years, with $760000.0 as the latest value for Q1 2025.

  • Quarterly Cost of Revenue rose 16.56% to $760000.0 in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $760000.0 through Dec 2025, down 74.87% year-over-year, with the annual reading at $760000.0 for FY2025, 74.87% down from the prior year.
  • Cost of Revenue for Q1 2025 was $760000.0 at Whitehawk Therapeutics, down from $790000.0 in the prior quarter.
  • The five-year high for Cost of Revenue was $927000.0 in Q4 2023, with the low at $179000.0 in Q1 2022.
  • Average Cost of Revenue over 4 years is $609846.2, with a median of $656000.0 recorded in 2023.
  • The sharpest move saw Cost of Revenue surged 317.57% in 2023, then dropped 14.78% in 2024.
  • Over 4 years, Cost of Revenue stood at $222000.0 in 2022, then surged by 317.57% to $927000.0 in 2023, then decreased by 14.78% to $790000.0 in 2024, then decreased by 3.8% to $760000.0 in 2025.
  • According to Business Quant data, Cost of Revenue over the past three periods came in at $760000.0, $790000.0, and $804000.0 for Q1 2025, Q4 2024, and Q3 2024 respectively.